Gender Discrimination Suits: Cases Against Pharma Continue Even As Payouts Slow
This article was originally published in The Pink Sheet Daily
Executive Summary
Novartis will pay $8m to settle second case; last year Daiichi Sankyo settled gender discrimination class action for the same amount and action against Bayer was dismissed following confidential resolution. Cases are ongoing against Merck and Forest.